PCI Benefit in Angina Clarified in New ORBITA-2 Analysis
Patients with stable angina but a high burden of symptoms benefit from percutaneous intervention (PCI), shows a new analysis of data that caught international attention.
Stay updated with breaking news from Robert Yeh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with stable angina but a high burden of symptoms benefit from percutaneous intervention (PCI), shows a new analysis of data that caught international attention.
Typical angina predicted PCI's efficacy in ORBITA-2
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Boston Scientific (NYSE:BSX) reported positive investigational device exemption (IDE) trial data for its Agent drug-coated balloon (DCB).
(UPDATED) In patients not taking antianginal meds, PCI clearly alleviated some—but not all—symptoms. What does that mean in practice?